single invest


AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases, and immunological disorders.

AdaptVac has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. AdaptVac is one of more than 500 companies that Accelerace already have accelerated.

Related startups